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Background: Osteochondrosis (OC(D)) is a juvenile osteo-articular disorder affecting several mammalian species. In
horses, OC(D) is considered as a multifactorial disease and has been described as a focal disruption of endochondral
ossification leading to the development of osteoarticular lesions. Nevertheless, OC(D) physiopathology is poorly
understood. Affected horses may present joint swelling, stiffness and lameness. Thus, OC(D) is a major concern for the
equine industry. Our study was designed as an integrative approach using omics technologies for the identification of
constitutive defects in epiphyseal cartilage and/or subchondral bone associated with the development of primary
lesions to further understand OC(D) pathology. This study compared samples from non-affected joints (hence lesion-free)
from OC(D)-affected foals (n = 5, considered predisposed samples) with samples from OC-free foals (n = 5) considered as
control samples. Consequently, results are not confounded by changes associated with the evolution of the lesion, but
focus on altered constitutive molecular mechanisms. Comparative proteomics and micro computed tomography analyses
were performed on predisposed and OC-free bone and cartilage samples. Metabolomics was also performed on synovial
fluid from OC-free, OC(D)-affected and predisposed joints.
Results: Two lesion subtypes were identified: OCD (lesion with fragment) and OC (osteochondral defects).
Modulated proteins were identified using omics technologies (2-DE proteomics) in cartilage and bone from
affected foals compare to OC-free foals. These were associated with cellular processes including cell cycle, energy
production, cell signaling and adhesion as well as tissue-specific processes such as chondrocyte maturation,
extracellular matrix and mineral metabolism. Of these, five had already been identified in synovial fluid of
OC-affected foals: ACTG1 (actin, gamma 1), albumin, haptoglobin, FBG (fibrinogen beta chain) and C4BPA
(complement component 4 binding protein, alpha).
Conclusion: This study suggests that OCD lesions may result from a cartilage defect whereas OC lesions may be
triggered by both bone and cartilage defects, suggesting that different molecular mechanisms responsible for the
equine osteochondrosis lesion subtypes and predisposition could be due to a defect in both bone and cartilage.
This study will contribute to refining the definition of OC(D) lesions and may improve diagnosis and development
of therapies for horses and other species, including humans.
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Osteochondrosis (OC(D)) has been described as a focal
failure or disruption of endochondral ossification [1] that
occurs in young, growing individuals. This condition af-
fects 10 to 30% of the equine population as well as other
animal species such as pigs, poultry and dogs and also
humans. Currently, the original term osteochondrosis
(OC) is used for the forms without loose fragments or
overt signs of inflammation, including subchondral bone
cysts. Osteochondritis dissecans (OCD) is used to refer to
presentations where osteochondral fragments separate
and become loose intra-articular bodies (joint mice), lead-
ing to further damage such as synovitis and pain accom-
panied by varying degrees of lameness [2]. In its early
subclinical stages, where focal areas of cartilage necrosis
are confined to the epiphyseal cartilage, the condition has
been referred to as dyschondroplasia [3], or more recently
osteochondrosis latens, whereas the presence of retained
cores of cartilage and focal areas of cartilage necrosis vis-
ible on macroscopic and radiographic examination is des-
ignated as osteochondrosis manifesta [4].
In horses, a multifactorial origin is commonly accepted,
including environmental factors (dietary imbalance and
biomechanical factors), physiological factors (growth, con-
formation and hormonal imbalance) and genetics [5-7].
Despite substantial research efforts made since the early
1990s, including gene mapping studies (for review see [8]),
OC(D) pathogenesis remains unclear [9], probably due to
the confusion regarding disease definition and the lack of
precise data about mechanisms of primary lesion forma-
tion [4]. In this respect two main hypotheses have been
put forward to explain the origin of primary lesions: the
vascular and the dyschondroplastic hypotheses. In the first
one, a local defect in cartilage canal blood supply, in a cer-
tain age window, may lead to focal ischemic necrosis of
growth cartilage and abnormal ossification [4,10,11]. In
the second hypothesis, primary lesions result from a local
failure of endochondral ossification [12]. A classification
has been proposed recently, based on anatomical and
functional aetiopathogenesis of lesion [13]. Histological
studies have made it possible to grossly divide primary le-
sions into two main groups [3,12,14]: 1) lesions with an
accumulation of chondrocytes apparently arrested in the
pre-hypertrophic stage and associated with necrotic areas,
and 2) lesions characterized by an alteration of mineral-
ized matrix, necrotic areas, and increased type VI collagen
immunoreactivity as well as cartilage cores retained in the
subchondral bone [15]. Taken together, these features sug-
gest a disruption of the endochondral ossification process
at the chondro–osseous junction that impairs cartilage re-
placement by bone tissue as the ossification front advances
with time [15]. In both hypotheses, shearing biomechan-
ical forces are thought to drive the development of dissect-
ing lesions and biomechanical influences may explain thelocal disruption of cartilage canals as well as the existence
of predisposition sites [9,11,16]. The picture is also com-
plicated due to the highly dynamic character of OC in
young foals. Indeed, even large lesions may heal spontan-
eously without leading to any pathology, probably due to
the high metabolic activity of juvenile cartilage that en-
ables growth and facilitates repair of the tissue [9,17].
There is clearly a need for a better understanding of OC
(D) molecular physiopathology in order to improve lesion
classification and increase positional cloning efficiency [9].
The aim of our study was to identify constitutive defects
and altered biological processes in epiphyseal cartilage
and/or subchondral bone associated with the development
of primary lesions. In agreement with what is currently
known, we considered that, in all joints, different molecu-
lar mechanisms are responsible for the development of
the different forms of OC(D). These mechanisms may re-
sult in differing susceptibility to specific biomechanical
forces, leading to a heterogeneous pathological profile.
Therefore, a novel experimental approach was taken for
the study of this pathology, in order to compare the prote-
ome of epiphyseal cartilage and subchondral bone sam-
pled from lesion-free joints of 10 month OC-free and OC
(D)-affected foals. Consequently, results are not con-
founded by changes associated with the lesion develop-
ment, disease progression or healing process.
Methods
Animal Care Committee
The experimental protocol number 0964 was reviewed
and approved by the Animal Care Committee of VetAgro
Sup (France), which abides by the requirements of Directive
86/609 of the European Community Council.
Animals and inclusion criteria
The study was based on 33 Anglo-Arabian foals obtained
from a unique stallion known to have OC-affected foals in
his progeny. None of the dams were diagnosed as OC(D)-
affected based on clinical examination. To reduce genetic
and environmental variability, foals were bred at the ex-
perimental station of the French National Stud (Station
IFCE de Chamberet) and mare-foal pairs were managed
by rotational grazing until the end of the grass season.
The osteo-articular status and identification of OC(D) le-
sions of each foal was determined between six to seven
months of age based on current knowledge of lesion de-
velopment and progression [17]. Clinical examination of
the foals included a qualitative visual assessment of lame-
ness, trauma, skin anomalies and joint effusion. Radio-
graphic examination was performed for metacarpo and
metatarsophalangeal joints as well as tarsocrural and
femoro patellar joints (12 views) and X-rays were evalu-
ated for the presence of OC(D) lesions. Additional X-rays
were taken to confirm the presence or absence of lesions
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were considered as affected if they had radiological evi-
dence of OC(D) at any predisposition site (i.e. the inter-
mediate ridge of the distal tibia, medial or lateral trochlear
ridge of talus, and medial malleolus). Femoro patellar
joints were considered OC(D)-affected if radiological
anomalies were observed on the lateral or medial trochlear
ridge of the femur. Foals were considered OC-free if they
did not show any sign of trauma, lameness or joint effu-
sion and their radiographic exam did not reveal any sign
of OC(D) lesions on any limb joint.
Among the 33 foals, 12 were diagnosed as OC(D)-af-
fected and 5 were selected for the study. Foals with signs of
external trauma were excluded. Selected foals were chosen
based on the affected joint and to balance groups in terms
of gender and age. These foals (OC1-OC5) showed at least
one lesion in tarsocrural joints (see Additional file 1: Table
S3). These foals did not present any signs of lameness. Foals
OC3, OC4 and OC5 were bilaterally affected, whereas foals
OC1 and OC2 were only affected in the right joint. Note-
worthy, no sign of OC(D) was observed in their femoro pa-
tellar joints. Five foals considered OC-free (OF1-OF5) were
selected, based on their soundness at clinical examination
combined with the absence of radiographic abnormalities
on any of the 12 views.
Foals were euthanized at 10 months by lethal intravenous
injection of T61 (Embutramide), a sedative drug used for
euthanasia in veterinary medicine. The presence/absence of
OC(D) lesions was macroscopically confirmed during nec-
ropsy by inspection of all limb joints, except for the coxofe-
moral and coffin joints (ie presence/absence of irregularities
or abnormalities at the articular cartilage surface). A ham-
mer and a-12-mm punch were used to collect cartilage and
subchondral bone cylindrical explants from the femoral
trochlea of OC-free and OC(D)-affected horses. As men-
tioned earlier all femoropatellar joints showed no gross or
radiographic evidence of disease. These samples were con-
sidered as predisposed samples if retrieved from the af-
fected group (OC1-5) and as control samples if retrieved
from the OC-free foals (OF1-5). Three consecutives
punches were taken in the middle of the trochlea (one for
proteomics, one for μCt and one for histology) (Figure 1).
All comparisons performed in our study involved
punches collected at the same location (see Picture P1
in the Additional file 1).
Histological analysis and immunochemistry
Osteochondral lesions for histological analysis were cut in
the sagittal plane to include five mm of subchondral bone
and fixed for 18 hours in a solution of 4% paraformalde-
hyde (PFA), decalcified for one month in 20 ml DC3 solu-
tion and embedded in paraffin. 5-μm sections were
stained with hematoxylin-eosin-saffron (HES) and safranin
O-Light Green (LGS).Proteomics
Cartilage and bone were carefully separated using a cut-
ter and a hammer and immediately placed in liquid ni-
trogen. Frozen cartilage (200 mg) and bone (150 mg)
samples were crushed in liquid nitrogen using a hammer
and a stainless steel mortar and pestle and then ground to
a fine powder in liquid nitrogen using a porcelain mortar
and pestle. Protein extraction and quantification(2-D Quant
Kit, Sigma Life Science), two dimensional electrophoresis
(2-DE) and spot identification were then performed as pre-
viously described [18]. Spot volume normalization was per-
formed using the Progenesis “Total Volume Ratio” option.
Descriptive statistics were done using R scripts and the
ade4 package. Principal component analysis (dudi.pca) and
between-class correspondence analysis (dudi.bca) were per-
formed to investigate differences between OC-free and OC
(D)-affected horses as well as heterogeneity between af-
fected samples. Spots having inertia above the third quar-
tile and showing at least a 50% change in abundance
between OC(D)-affected foals and OC-free were consid-
ered as associated with the pathology. A hierarchical clus-
tering (Pearson correlation) was also performed based on
a subset of differentially expressed spots (t-test, adjusted
p-value <0.2).
Comparative micro computed tomography (μCT)
Cylindrical cartilage and subchondral bone explants
were obtained from undamaged femoro patellar joints
of both OC-free and OC(D)-affected foals using a 12-
mm punch. Samples were stored in 70% ethanol at 4°C
before use. Scans were performed using approximately
15-μm voxel sizes (Phoenix nanotom™, GE measure-
ment and control). The scanner used a tungsten source
X-ray tube operating at 100 KV and 70 μA. Data acqui-
sition from each sample required 90 minutes. Images
were reconstructed using Phoenix datos*|x* CT soft-
ware™. For measurements, the Microview™ software was
used and the calibration for mineral density in the scans
was performed with the use of a phantom (hydroxyapa-
tite). For each sample, two regions of interest (ROIs)
were designed manually corresponding to the subchon-
dral bone area (less than 2 mm from the cartilage area)
and to the trabecular area (between 3 and 4 mm under
the cartilage area). Morphometry parameters measured
were: bone mineral density (BMD), bone volume frac-
tion (BV/TV), trabecular thickness (Tb.Th), trabecular
number (Tb.N), and trabecular spacing (Tb.Sp). A prin-
cipal component analysis (dudi.pca) was done using R
scripts and the ade4 package. Likewise, between-class
correspondence analysis (dudi.bca) was performed to
identify the most significant parameters differentiating
OC(D)-affected and OC-free samples. Hierarchical clus-
tering was performed using R (hclust), based on the 3
most significant parameters.
Figure 1 Study design. Ten foals were allocated to two groups based on clinical and radiographic assessment: OC-free (n = 5) and OC-affected
(n = 5). OC foals presented at least one talocrural lesion whereas femoropatellar joints were normal. Lesions were sampled and classified histologically.
Explants comprising both cartilage and 5 mm of subchondral bone were harvested on femoropatellar joints and considered as healthy samples if
retrieved from OC-free foals and as predisposed samples if retrieved from OC-affected foals. Samples were used for comparative proteomics and micro
computed tomography (μCT). Tibiotarsal joint synovial fluids were also collected from OC-free and OC(D)-affected foals (affected limb and contralateral
non-affected limb for foals non-bilaterally affected) and used for comparative metabolomics. Blue arrows correspond to OC-free samples, purple arrows
to predisposed samples and red arrows to OC(D)-affected samples.
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Synovial fluid was collected from tibiotarsal joints from
OC-free and OC(D)-affected foals. For foals not presenting
bilateral OC(D) lesions, synovial fluid was also collected
from the contralateral OC-free joint. Samples were thawed
at room temperature and 600 μL added to 5-mm NMR
tubes prefilled with 100 μL deuterium oxide for field lock-
ing. The proton spectra were acquired at 500 MHz on a
Bruker Advance III spectrometer, with the noesy1D se-
quence for water suppression. The temperature was 297 K.
The time domain raw signals (free induction decays: FIDs)
were collected on 32 K points for a spectral window of
6000 Hz and 64 transients. The FIDs were processed with
the MestReNOVA software. The Fourier transform was
performed with an exponential function producing a
0.3 Hz line broadening. Spectra were phased and the base-
line correction was performed with three points at 0, 5,
and 9 ppm. Each spectrum was calibrated using acetic acid
signal at 1.92 ppm in blood spectra. The spectral region be-
tween 0 ppm and 9 ppm was divided into 9000 spectral re-
gions of 0.001 ppm width called buckets. Each bucket is
labeled with its median chemical shift value. The water re-
gion, between 4.6 and 5 ppm, was excluded. Consideringthe possible variation of the sample concentration, the
spectra were normalized according to the “Probabilistic
Quotient Normalization” method [19]. Statistical analyses
consisted of a Principal Component Analysis (PCA) per-
formed using the statistics SIMCA P + software (ver. 12,
Umetrics AB, Umea, Sweden). The results are presented as
a score plot constructed with the two principal compo-
nents describing the spectra and the loading plots describ-
ing the importance of the variables (here, the buckets) to
compute the principal components.
Results
Osteochondrosis lesion typology
During necropsy, two major types of macroscopic le-
sions were observed on the lateral trochlear ridge of the
talus of the five 10 month-old OC(D)-affected horses.
Firstly, articular cartilage fragments were observed at the
distal aspect of the trochlea, a typical location of OCD
fragments. These samples were called OCD samples
(horses OC1, OC2 on Figure 2, upper panel) and showed
a fragment partially detached from the underlying sub-
chondral bone. Secondly, some lesions located on the
middle of the trochlea, resembled small osteochondral
Figure 2 Identification and characterization of OC(D) lesion subtypes. Upper Panels - Macroscopic views of the talus trochlea of one OC-free
and five OC-affected foals. Two major types of osteochondrosis lesions could be distinguished: cartilage fragments corresponding to OCD lesions
(horses OC1, OC2, and OC4; open arrows) and osteochondral defect corresponding to OC lesions with varying degrees of cartilage loss (horses
OC3, OC5, and OC4; black arrow). Lower Panels - Histological views of osteochondrosis lesions (light green/safranin-O stain). Irregularities and
reduced thickness were observed at the cartilage surface. The absence of staining both in and close to the lesion indicates reduction in
proteoglycan content. Abnormal cartilage cores were also seen in the subchondral bone (black arrows).
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superficial cartilage defect to an absence of articular cartil-
age as far as the subchondral bone (horses OC3, OC4, and
OC5 on Figure 2). These samples were called “OC sam-
ples”. It is worth noting that OC4 presented both OCD
and OC lesions. At necropsy, the subchondral bone of
OC-affected horses seemed easier to cut.
Comparison between samples collected from the lat-
eral trochlear ridge of the talus of OC-free horses and
OC(D)-affected horses showed the presence of irregular-
ities and reduced thickness of articular cartilage, espe-
cially for horse OC5 (lower panel Figure 2). Staining was
absent for this animal, suggesting altered proteoglycan
content. Horses OC1 and OC2 presented abnormal car-
tilage cores retained in the subchondral bone.
Type-I collagen immunostaining revealed large areas of
chondrocyte dedifferentiation in the lesion. In addition,
type-VI collagen was widely distributed in the lesion (upper
panel Figure 3), contrasting with the usual localization at
the pericellular region (chondron) in OC-free articular car-
tilage. Chondrocyte dedifferentiation and type-VI collagen
expression are suggestive of fibrocartilage. Abnormal chon-
drocyte clusters were observed at different localizations:
surrounding the lesions, close to the lesions, and distant
from the lesions in horses OC1-OC4 (lower panel Figure 3).
Based on histology, OC lesions were classified into two
groups: 1) osteochondral defects with invagination of ar-
ticular cartilage, progressive dedifferentiation and high
type-VI collagen expression (horses OC3 and OC4); and 2)
lesions with major cartilage loss (horse OC5), with low
type-VI collagen expression.
Proteomics comparative analysis
Comparison between bone and cartilage samples from
the five OC-free (control samples) and the five OC(D)-
affected horses (predisposed samples) was performedusing our previously published method [18]. A total of
554 and 639 reproducible spots were observed on cartil-
age and bone gels, respectively.
Principal Component Analysis (PCA) showed an im-
portant heterogeneity for cartilage and bone samples, es-
pecially for OC(D)-affected foals (Figure 4a). Hierarchical
clustering (HCL) was also performed based on differen-
tially expressed spots (Figure 4b). Histology, PCA and
HCL corroborated the classification of samples as OCD
and OC in both cartilage and bone. Furthermore, OCD-
predisposed samples (horses OC1, OC2, and OC4) were
clustered near OC-free samples in bone, in contrast to
OC-predisposed ones (horses OC3 and OC5).
Between-class correspondence analysis highlighted 23
(cartilage) and 37 (bone) modulated proteins between OC-
free and predisposed samples (Additional file 1: Tables S1
and S2). In cartilage, the identified differentially expressed
proteins are mainly involved in growth, proliferation and
development, cellular assembly and organization, cell com-
munication, cell adhesion, lipid and protein metabolism,
energy production, vesicle-mediated transport and immune
system processes (Additional file 1, cartilage annotation).
Proteins associated with osteoarticular diseases and devel-
opmental disorders such as achondrogenesis, dysplasia, or
Stickler and Kniest syndromes were also modulated.
In subchondral bone, differentially modulated proteins
are mainly involved in developmental processes, cellular
component organization, cell-to-cell signaling, cell adhe-
sion, protein metabolic processes, protein transport and
response to stimulus (Additional file 1, bone annotation).
Several plasma proteins, including fibrinogen-β and -γ,
hemopexin, transferrin, complement component 4 bind-
ing protein α, as well as apolipoprotein A1 and fetuin B,
were modulated in both OC- and OCD-predisposed sam-
ples. In addition, five of the modulated proteins had also
been identified in synovial fluid samples from OC(D)-
Figure 3 Investigation of type-VI collagen localization and chondrocyte organization. Upper Panel - Type-VI collagen localization by
immunostaining. Both lesion types (OCD [f] and osteochondral defects (OC) [s]) were characterized by positively stained areas (arrows) indicative
of cartilage dedifferentiation leading to the formation of local scar tissue (fibrocartilage). Lower Panel - Magnification views (x20) of animals
OC1-OC4 showing chondrocyte clusters located surrounding (s) or close to the lesions (c), which may reflect a healing process is underway.
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fibrinogen beta chain and complement component 4 bind-
ing protein alpha (denoted by # in Additional file 1: Table
S1 and Table S2).
Validation by comparative μCT morphometry analysis of
subchondral bone
Bone mineral density (BMD), bone volume fraction
(BV/TV), trabecular thickness (Tb.Th), trabecular number
(Tb.N), and trabecular spacing (Tb.Sp) were measured on
subchondral bone from the middle of femoral trochlea
explants. These parameters were used for BCA analysis,
highlighting BMD, Tb.N and Tb.Th as discriminating pa-
rameters. Hierarchical clustering based on these parame-
ters distinguished OC- from OCD-predisposed samples
and OC-free samples, in agreement with observed
histological features and data obtained from proteomics.
Again, OCD-predisposed samples (horses OC1, OC2
and OC4) were clustered with OC-free samples (Figure 5
and Additional file 1, microCt).
Bone mineral density was significantly reduced in sub-
chondral bone from OC-predisposed samples (horses
OC3, OC4 and OC5; Figure 5). In addition, bone structure
was disrupted, with samples showing a reduced number of
trabeculae (30%) and increased trabecular spacing (80%
increase). The μCt analysis did not reveal any variation in
bone samples from foals affected by OCD.
Metabolomic study of synovial fluid
A PCA based on the synovial fluid NMR spectra dis-
criminated between OC-affected, OC-free and OCD-
affected samples in PC1 (Figure 6A), in good agreement
with proteomic and histological features. PC2 mainly
discriminated injured and healthy joints from OCD-
affected horses, but did not discriminate well between
healthy joints from OCD-affected (OC1 and OC2 left
joints) and OC-free horses. The loading plots (Figure 6B)
provide the weight of each spectral region, showing thatmost metabolites positively contribute to PC1, with lac-
tate, glucose, acetate, creatine and pyruvate having the
heaviest loadings. Thus, elevated levels of these metabo-
lites characterize injured joints from OCD-affected horses
(OC2_R, OC4_L and OC4_R), and to some extent, healthy
joints from OCD-affected horses (OC1_L and OC2_L). El-
evated levels of lactate and acetate are suggestive of hyp-
oxic and acidotic status whereas increased glucose and
pyruvate levels indicate a low efficiency of glycolysis and
reduced aerobic processes. Elevated levels of branched-
chain amino acids and creatine may be indicative of in-
creased proteolysis. In contrast, synovial fluid collected
from joints presenting OC lesions (horses OC3_L, OC5_R
and OC5_L) had reduced levels of glucose, pyruvate and
lactate, and an increase in ketone bodies including hydro-
xybutyrate. This is suggestive of a reduced anaerobic
glycolytic rate as well as the use of fatty acids as a source
of energy.
Discussion and conclusion
The terms “osteochondrosis” and “osteochondritis dissecans”
have been overused in horses, being applied indiscrimin-
ately to a variety of lesions in the skeleton of horses,
without respect to recognized differences in their eti-
ology, pathogenesis and clinical characteristics. Con-
versely in humans, several severe conditions were initially
grouped under the heading of osteochondrosis [21], but
have now been subdivided into about 50 syndromes [22].
Based on a comprehensive and integrative approach in-
cluding radiographic, histological, μCT, proteomic and
metabolomic techniques, our study aimed at improving
our understanding of equine osteochondrosis OC(D) phys-
iopathology. Histology showed many features consistent
with previously described OC(D) lesions in several species,
including cartilage retained in the underlying subchondral
bone, changes in matrix composition, chondrocyte clusters,
and the presence of scar tissue similar to fibrocartilage
[12]. Chondrocyte clusters have been described as a
Figure 4 Statistical distinction between OC-free (n = 5) and OC(D)-predisposed (n = 5) bone and cartilage samples. (A) Principal
Component Analysis (PCA) of Proteomic Data. The PCA reveals a great heterogeneity between predisposed samples in both cartilage and bone.
Furthermore, OCD samples (horses OC1, OC2 and OC4) cluster near healthy samples in bone, in contrast to OC (osteochondral defects) (horses
OC3 and OC5). This suggests that OCD may result mainly from a cartilage defect, whereas OC may result from a combined cartilage and bone
defect. (B) Hierarchical Clustering (HCL) of Proteomic Data. Differentially expressed spots (97 in cartilage, 126 in bone) between healthy OC-free
(n = 5) and predisposed (n = 5) samples collected from OC-affected and OC-free foals were used to perform HCL. A distinction could be made
between OC-affected and OC-free foals, as well as OCD and OC (osteochondral defects) in both cartilage and bone. In addition, OCD-affected
foals have similar profile to OC-free foals based on their bone proteome, suggesting that this lesion subtype shows only a minor defect in bone.
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thought to result from proliferating chondrocytes attempt-
ing to repair the tissue [23,24]. In addition, lesions are
commonly classified into fragments (OCD) and OC lesions
(including cyst). Histology, PCA and HCL concurred with
this commonly accepted classification. Histological features
of samples from foals OC3 and OC4, showing a progres-
sive invagination of cartilage into bone, suggest that these
osteochondral defects may be early cystic lesions. However,
it seems unlikely that the lesion observed for foal OC5
would evolve into a cyst since we observed a severe cartil-
age loss. Thus, histology revealed the heterogeneous nature
of OC type lesions, showing various degrees of cartilage in-
vagination and cartilage loss up to the subchondral bone.
This heterogeneity may be related to a progressive degen-
eration of epiphyseal cartilage, leading finally to cartilage
loss and development of a thin fibrocartilage layer, or alter-
natively, to different pathological entities.
Our proteomic study was designed to explore the hy-
pothesis of a putative constitutive defect in epiphyseal
cartilage and/or subchondral bone associated with the
development of primary lesions. We focused on lesion-
free cartilage and bone sampled from femoropatellar
joints of OC-free and OC(D)-affected horses. Since OC
(D) is a very dynamic disease, the reliable identification
of OC-free controls is crucial and errors in foal classifi-
cation may represent one potential weakness of this de-
sign. Therefore, radiographs and clinical examinations
were performed on foals between six to seven months of
age, when lesion number reaches a peak [17]. AtFigure 5 Comparison of subchondral bone structure using micro com
the subchondral bone structure between healthy (n = 5) and predisposed s
density (BMD), the ratio between bone volume and total volume (BV/TV), t
trabecular spacing (Tb,sp). Between-class correspondence analysis highlight
OC-affected and OC-free samples. Hierarchical clustering (A) based on thes
OC2 and OC4) were clustered with healthy samples, whereas OC-predisposed
suggested that OC-predisposed samples presented modified bone structure.
predisposed group (B) seemed to confirm this assumption. The data suggeste
predisposed samples from osteochondral defect-affected foals, whereas Tb.sp
in bone-predisposed samples from OCD-affected foals.necropsy (10 months of age, when lesions are well estab-
lished and will persist thereafter), the presence of lesions
was macroscopically checked for all forelimb and hind-
limb joints, but cervical intervertebral joints, which
could show a high incidence of OC, were not examined.
Since limb and cervical lesion scores have been reported
to be highly correlated (for instance 0.69 in [25]), errors
in foal classification may however be limited. In addition,
OC-free foals may be genetically predisposed but have
not yet encountered environmental factors triggering the
disease and we cannot rule out that OC-free foals may
have had lesions which may have spontaneously healed
before the first radiographic exam. These limitations
apply to most studies performed to date on OC(D), espe-
cially genetic mapping studies. Furthermore, considering
foals with spontaneous healing as OC(D) affected is still a
subject of debates. Indeed, one could hypothesize that
minor defects resembling dyschondroplasic lesions may
be quite a common feature of developing cartilage, that re-
sorb spontaneously except in OC(D) predisposed foals. In
our opinion, our proteomic data provide good validation
of the OC-free status, since control samples are well-
clustered whereas affected samples exhibit a great variabil-
ity as shown in our PCA analysis.
Our study adopted a novel integrative approach using
several techniques to confirm observations, as opposed
to a single technique approach which may have pro-
vided equivocal results. The weakness of the study lies
with the animal species (horse) used which meant low
n-numbers. The study was not designed to test anyputed tomography (μCT). μCT analyses were performed to compare
amples (n = 5). Five parameters were measured: the bone mineral
he trabecular thickness (Tb,th), the trabecular number (Tb.nb) and the
ed BMD, Tb,nb and Tb.sp as discriminating parameters between
e parameters showed that OCD-predisposed samples (horses OC1,
samples (OC3 and OC5) were clustered separately. These observations
The measures of the ratios between means of healthy and each
d that the BMD and the Tb,nb were reduced in subchondral bone
was increased. Interestingly, the μCt analysis did not reveal any variation
Figure 6 Metabolomic study of synovial fluid. Synovial fluids were collected from tibiotarsal joints from OC-free and OC-affected foals. When
possible, synovial fluid from OC foals was also collected from the contralateral healthy joint. Synovial fluids were analyzed by NMR metabolomics
and a PCA based on obtained spectra was performed (A) The score Plot of the PCA Model shows discrimination between healthy, OCD-affected
and OC-affected joints, but not between healthy joints from OC-affected (OC1_L and OC2_L) and OC-free foals. L = left joint; R = right joint;
OF = OC-free foal; OC = affected foal; Blue: healthy joint; Green: OC lesion (osteochondral defects); Red: OCD lesion (fragments). (B) Proton NMR
spectrum of synovial fluid (upper graph) and loading plot (lower graph) of the first principal components obtained with the PCA model. The
importance of the buckets (y-axis) is plotted as a function of their chemical shift (x-axis). The corresponding metabolites are increasing along
the component when positive and decreasing along the component when negative. Metabolite attributions: 1: branched-chain amino acids
including valine, leucine, and isoleucine; 2: lactic acid; 3: alanine; 4: acetic acid; 5: acetone; 6: pyruvic acid; 7: trimethylamine; 8: creatine; 9: glucose;
10: aromatic amino acids including tyrosine and phenylalanine.
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study. Based on our proteomic results, PCA showed that
equine osteochondrosis predisposition might be due to adefect in both cartilage and bone tissues. Several proteins
were found to be modulated and five of the differentially
expressed proteins, ACTG1, ALB, HP, FBG and C4BPA
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identified in synovial fluid from OC(D)-affected horses
[20]. In addition, a between-class correspondence analysis
highlighted several proteins specifically involved in suscep-
tibility to each lesion subtype, suggesting that common as
well as distinct molecular mechanisms may be involved in
the etiopathogenesis of each osteochondrosis subtype.
This is in good agreement with the observed low pheno-
typic and genetic correlations between different joints
[26-29], suggesting that OC and OCD may be considered
different traits and that future genome-analysis studies
should focus on predilection sites rather than the entire
disease. Altogether, these data agree with the hypothesis
that OC(D) joint specificity is due to the interaction of dif-
ferent molecular mechanisms, which are altered in all
joints (systemic defect) but trigger a different susceptibility
(joint specificity due to the different biomechanical
constraints sustained by the joints).
Molecular mechanisms in cartilage
In cartilage, the down-regulation of COL3A1 and up-
regulation of COL6A1 and HAPLN1, proteins involved in
ECM structure and chondrocyte microenvironment and
micromechanical regulation [30] suggest a production
of altered ECM. In addition, down-regulation of CLU, a
glycoprotein providing a protective effect for cells at the
fluid-tissue interface, is in line with the previously
observed down-regulation in advanced osteoarthritic
cartilage [31] suggesting a reduced protection against
biomechanical stress.
Furthermore, the down-regulation of CKB and
NDUFS1 may be indicative of an altered energy homeo-
stasis leading to defective cartilage maturation in OC(D)-
affected foals. CKB is required for normal development
and mineralization of the growth plate and its expression
level is related to chondrocyte maturation stages [32].
CKB is thought to play a key role during the switch
from oxidative metabolism to glycolysis associated with
the hypertrophic differentiation process. In line with a
defective cartilage maturation hypothesis, up-regulation
of proteins involved in vesicle transport and ubiquitin-
dependent protein degradation by the proteasome (VCP
and PSMB3), down-regulation of the chaperone proteins
FKBP10 and CLU as well as translation elongation factor
EEF1D suggest impaired protein biosynthesis, folding, se-
cretion and degradation. Taken together, these findings are
consistent with data obtained in human OCD fragments,
showing chondrocytes with abnormal accumulation of
ECM proteins in distended rough endoplasmic reticulum
(ER) [33], suggesting that OCD might be an ER storage
disease. However, some specificity was observed accor-
ding to lesion subtype. For example in OC-predisposed
cartilage, up-regulation of HSPA1A and PDIA3—which
play a role in the folding of newly synthesizedglycoproteins— suggests that a partial ER-stress response
may have been triggered. Since ER stress triggers metabol-
ism changes [34], such a hypothesis may be consistent
with our metabolomic data, showing reduced glycolysis
and increased utilization of fatty acids to produce energy,
a characteristic feature of the inflamed rheumatoid joint
[35]. Interestingly, our study in French trotters also identi-
fied ER stress and mitochondrial dysfunction as key fac-
tors involved in OCD [36]. In contrast, HSPA1A was
down-regulated in OCD predisposed cartilage. However,
in this latter case, modulation of additional genes involved
in energy metabolism, such as ENO1 is consistent with
our metabolomics findings, showing a reduced aerobic
glycolysis and an increased proteolysis to overcome this
defect and produce the required ATP.
These differences may lead to an alternative outcome
according to lesion subtype: OC susceptibility appeared to
be mainly associated with disrupted ECM structure.
Down-regulation of several major ECM constituents such
as COL2A1, COL3A1, SPARC and COL11A2, as well as
COL11A1, which are essential for maintaining the spacing
and diameter of type-II collagen fibrils [37] and MFG-E8,
a protein preserving the structure of articular cartilage and
stabilizing chondrocyte adhesion to the ECM [38], may be
indicative of a defective ECM.
In contrast, OCD susceptibility seemed to be associ-
ated with impaired ECM mineralization, as suggested
by down-regulation of AHSG, a glycoprotein which
knockout in mice leads to growth plate defects, includ-
ing a reduced number of hypertrophic chondrocytes as
well as accelerated mineralization [39]. This defect may
be caused by defective hypertrophic chondrocyte ter-
minal differentiation and up-regulation of major cyto-
skeletal components (VIM, ACTG1, ACTA1). This is in
agreement with the essential role of the cytoskeletal net-
work during chondrogenesis and hypertrophy [40]. The
defective cartilage mineralization occurring in OC may
result in a failure of osteoclast remodeling. Decreased
or delayed mineralization combined with altered ECM
structure may therefore lead to impaired epiphyseal car-
tilage biomechanical properties, making it prone to the
development of fragments.
Molecular mechanisms in bone
Horses presenting OC lesions had softer and more vascu-
larized subchondral bone, and osteonectin—a glycoprotein
known to promote angiogenesis, increase metalloprotein-
ase activity, and inhibit bone mineralization—was shown
to be up-regulated, together with other plasma proteins.
One of these was apolipoprotein A1, which in bone, may
promote cholesterol efflux and affect HDL levels, leading
to the alteration of bone mineral density and trabecular
architecture. There is growing evidence suggesting that
abnormalities in lipid metabolism may impact bone
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ous sources of cholesterol are essential for osteoclast
formation as well as survival [41] and several studies have
suggested a relationship between HDL, osteoblasts, osteo-
clasts, and bone mineral density (for review see [42]). Up
regulation of AZGP1 - an adipokine involved in lipid
metabolism - may provide clues about the link between
body weight, conformation and OC susceptibility. Indeed
a genetic linkage between AZGP1 and body weight has
been shown in mice [43] and polymorphisms in this gene
have been associated with high body weight, body length
and chest girth in cattle [44].
OC-affected samples showed more modulated proteins
than OCD-affected samples and fold changes were higher
in these samples suggesting that OC lesions may result
from a major bone defect, whereas OCD lesions may be
associated with a slight bone defect. In line with our μCt
data, defective mineralization and an altered subchondral
bone structure are the main hallmarks of samples from
OC-affected horses. Proteomic data agree with this finding
since several modulated proteins are associated with bone
mineralization and bone remodeling. For example, down-
regulation of ATP6V1A may impair ATP production,
which is essential for osteoclasts to generate the acidic en-
vironment required for the digestion of the organic bone
matrix [45] as well as proper osteoblast differentiation and
activation [46]. Likewise, down-regulation of CKB, AHSG
and CA may also be associated with impaired bone
mineralization process [47,48].
Together, our results suggest that, in equine osteo-
chondrosis, the different lesion subtypes may be due to
different underlying molecular mechanisms and that the
predisposition could be due to a defect in both bone and
cartilage tissues. This is in line with observations made
for osteoarticular diseases in other species, which are
often associated with cartilage disruption extending into
the underlying subchondral bone (for review see [49]). A
constitutive cartilage defect may be responsible for OCD
physiopathology, whereas combined cartilage and bone
defects may trigger OC. However, the precise mecha-
nisms linking cartilage and bone defects remain to be
elucidated and it is not clear whether a primary cartilage
defect triggers a bone defect (or vice versa) or whether
both tissues are independently affected.
Differentially expressed plasma proteins highlighted in
this study, such as haptoglogin, hemopexin, fetuin, apoli-
poprotein A1 and transferrin may represent relevant
diagnostic biomarkers, but further studies are needed to
evaluate their diagnostic or prognostic significance. Like-
wise, proton NMR spectroscopy enabled the investiga-
tion of low molecular weight molecules present in the
synovial fluid from the tibiotarsal joints of OC-free and
OC(D)-affected foals, a technique which has already
been successfully applied to study pathological synovialfluids in humans [50] and horses [51]. In conclusion,
our data will contribute to refining the definition of
equine osteochondrosis lesion subtypes and the under-
standing of the underlying molecular mechanisms in-
volved for their development. This may help improving
diagnosis and developing relevant prevention strategies
or treatments for horses and other species.
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